Company: INDP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010099
Chunk: 6

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 8
Chunk 6
---
CHEDULE OF EXERCISE PRICE OF OUTSTANDING STOCK OPTIONS 

    Exercise price 
    Options  outstanding 

    $0.01 - $8.00 
     1,861,499 
  
    $0.01 - $8.00 
     1,861,499 
  
    $8.01 - $16.00 
     992,250 
  
    $16.01 or higher 
     33,448 
  
    Total 
     2,887,197 

NOTE 6: CAPITALIZATION

    a.
    As of March 31, 2025 and December 31, 2024, the Company had 200,000,000 shares of common stock authorized and 16,034,444 and 12,013,901 shares issued and outstanding, respectively. As of March 31, 2025 and December 31, 2024, the Company had 5,000,000 shares of preferred stock authorized. There were no shares of preferred stock issued or outstanding as of March 31, 2025 and December 31, 2024. As of March 31, 2025 and December 31, 2024, there were warrants outstanding to purchase an aggregate of 8,745,923 and 6,675,853 shares of common stock, respectively. As of March 31, 2025, these warrants are exercisable at a weighted average price of $4.54 and their weighted average remaining contractual term is 3.7 years.

    b.
    On January 16, 2025, the Company completed a private placement offering pursuant to which the Company sold and issued to certain investors an aggregate of 2,109,383 shares of common stock and warrants to purchase 2,109,383 shares of common stock (the “January 2025 Warrants”). The shares and January 2025 Warrants were sold on a combined basis for consideration of $1.065 for one share and one January 2025 Warrant. The January 2025 Warrants are immediately exercisable at an exercise price of $0.94 per share and expire five years from the date of issuance. The total net proceeds were approximately $2.0 million, after deducting placement agent and other offering expenses in the amount of approximately $0.25 million. In February 2025, the Company filed a registration statement to register the resale by the investors of the shares of common stock and